SMITHS FALLS, ON, Oct. 1, 2015 /CNW/ - Tweed Inc. (Tweed), wholly owned subsidiary of Canopy Growth Corporation (Canopy Growth) (TSXV: CGC), and DNA Genetics are excited to announce a first-in-kind exclusive partnership between Canada's leading Licensed Producer and one of the most widely recognized and acclaimed global brands in cannabis breeding and genetics.
Over the past decade, genetics bred by DNA have won more than 125 awards around the world transforming DNA Genetics into a global powerhouse for breeding and growing truly best-in-class strains. The exclusive Canadian partnership will see Tweed leverage DNA's expertise to bring its own product offering to new heights, and to launch it's own breeding program to bring new, exclusive DNA-bred strains to Tweed customers.
"We view ourselves as being the best in the industry at what we do, and we only want to work with the best producer and that is Tweed," said Don of DNA Genetics. "Providing the best possible cannabis means combining all the right processes, with the right infrastructure and then nurturing and identifying the best genetics for every strain. We're excited to be part of that at Tweed." Added Aaron, the other half of DNA Genetics: "And let's face it – you can't miss the chance to grow some world class Chocolope in an old chocolate factory."
"We think customers will look at this as a big win," said Mark Zekulin, President of Tweed. "Earlier this month we teamed up with the world leader in standardized medicinal cannabis with the acquisition of Bedrocan Canada. Now on the other end of the spectrum we have added an award-winning global powerhouse in breeding and genetics, acclaimed for the unique strain profiles their cannabis possesses."
The partnership will see DNA Genetics provide ongoing consulting services to Tweed, while assisting in phenotyping and grow method developments. Through the Tweed-DNA breeding program, the only place where Canadian patients will be able to acquire true, certified DNA strains grown to DNA standards will be Tweed.
Here's to future growth … Powered by DNA.
About Canopy Growth:
Canopy Growth is Canada's first publicly traded medical marijuana company and the first geographically diversified producer with multiple licenses under the Marihuana for Medical Purposes Regulations. Through its wholly owned subsidiaries, Tweed, Bedrocan and Tweed Farms, the Company operates state-of-the-art production facilities throughout Ontario and distributes marijuana across the country to Canadian patients managing a host of medical conditions.
The Company is dedicated to educating healthcare practitioners, providing consistent access to high quality medication, and furthering the public's understanding of how marijuana is used for medical purposes.
DNA Genetics was founded in Amsterdam back in 2004 and is known for the creation of many cannabis cup winning strains! In just over 10 years, DNA has won over 125 awards from prestigious cannabis events in several countries.
Notice regarding Forward Looking Statements
This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or any of its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
Although Canopy Growth Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The factors identified above are not intended to represent a complete list of the factors that could affect the Company or any of its subsidiaries. The forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
SOURCE Canopy Growth Corporation
Image with caption: "Don and Aaron from DNA Genetics, shown in Tweed's Smiths Falls facility. (CNW Group/Canopy Growth Corporation)". Image available at: https://photos.newswire.ca/images/download/20151001_C5597_PHOTO_EN_510045.jpg
For further information: Jordan Sinclair, Communications Manager, firstname.lastname@example.org, 613-706-2185 ex: 309